MAPT and Alzheimer disease: The mechanisms through which Aβ oligomers contribute to the neuropathogenesis associated with AD progression encompass receptor interaction, disruption of cell membranes, impairment of mitochondrial function, dysregulation of calcium homeostasis, and the induction of tau pathology (Huang and Liu, 2020).